These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31403685)

  • 61. Medulloblastoma: survey of factors possibly influencing the prognosis.
    Müller W; Afra D; Schröder R; Slowik F; Wilcke O; Klug N
    Acta Neurochir (Wien); 1982; 64(3-4):215-24. PubMed ID: 7136866
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene.
    Kraus JA; Oster C; Sörensen N; Berthold F; Schlegel U; Tonn JC; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 2002 Apr; 28(2):136-41. PubMed ID: 11972800
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Medulloblastoma variants and survival at a children's hospital.
    Craver R; Sandquist D; Nadell J; Velez M
    Fetal Pediatr Pathol; 2011; 30(1):53-9. PubMed ID: 21204667
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sporadic medulloblastomas contain oncogenic beta-catenin mutations.
    Zurawel RH; Chiappa SA; Allen C; Raffel C
    Cancer Res; 1998 Mar; 58(5):896-9. PubMed ID: 9500446
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Germline mutations in FGF receptors and medulloblastomas.
    Bourdeaut F; Miquel C; Di Rocco F; Grison C; Richer W; Brugieres L; Pierron G; James S; Baujat G; Delattre O; Collet C
    Am J Med Genet A; 2013 Feb; 161A(2):382-5. PubMed ID: 23325524
    [No Abstract]   [Full Text] [Related]  

  • 66. Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.
    Keil VC; Warmuth-Metz M; Reh C; Enkirch SJ; Reinert C; Beier D; Jones DTW; Pietsch T; Schild HH; Hattingen E; Hau P
    AJNR Am J Neuroradiol; 2017 Oct; 38(10):1892-1898. PubMed ID: 28798218
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.
    Bien-Willner GA; López-Terrada D; Bhattacharjee MB; Patel KU; Stankiewicz P; Lupski JR; Pfeifer JD; Perry A
    Neuro Oncol; 2012 Jul; 14(7):831-40. PubMed ID: 22573308
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic markers in paediatric medulloblastoma: a Paediatric Oncology Group Study.
    McLendon RE; Friedman HS; Fuchs HE; Kun LE; Bigner SH
    Histopathology; 1999 Feb; 34(2):154-62. PubMed ID: 10064395
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.
    Erdreich-Epstein A; Robison N; Ren X; Zhou H; Xu J; Davidson TB; Schur M; Gilles FH; Ji L; Malvar J; Shackleford GM; Margol AS; Krieger MD; Judkins AR; Jones DT; Pfister SM; Kool M; Sposto R; Asgharzadeh S
    Clin Cancer Res; 2014 Feb; 20(4):827-36. PubMed ID: 24300787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of BARHL1 in medulloblastoma is associated with prolonged survival in mice and humans.
    Pöschl J; Lorenz A; Hartmann W; von Bueren AO; Kool M; Li S; Peraud A; Tonn JC; Herms J; Xiang M; Rutkowski S; Kretzschmar HA; Schüller U
    Oncogene; 2011 Nov; 30(47):4721-30. PubMed ID: 21602885
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours.
    Goschzik T; Zur Mühlen A; Kristiansen G; Haberler C; Stefanits H; Friedrich C; von Hoff K; Rutkowski S; Pfister SM; Pietsch T
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):135-44. PubMed ID: 24894640
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ATM gene mutations are not involved in medulloblastoma in children.
    Liberzon E; Avigad S; Cohen IJ; Yaniv I; Michovitz S; Zaizov R
    Cancer Genet Cytogenet; 2003 Oct; 146(2):167-9. PubMed ID: 14553952
    [TBL] [Abstract][Full Text] [Related]  

  • 73. ASPM gene expression in medulloblastoma.
    Vulcani-Freitas TM; Saba-Silva N; Cappellano A; Cavalheiro S; Marie SK; Oba-Shinjo SM; Malheiros SM; de Toledo SR
    Childs Nerv Syst; 2011 Jan; 27(1):71-4. PubMed ID: 20694558
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rare cases of medulloblastoma with hypermutation.
    Bagchi A; Beddows I; Cornelius A; Robinson GW; Jewell SD
    Cancer Rep (Hoboken); 2022 May; 5(5):e1521. PubMed ID: 34351088
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Calbindin-d(28k): a marker of recurrence for medulloblastomas.
    Pelc K; Vincent S; Ruchoux MM; Kiss R; Pochet R; Sariban E; Decaestecker C; Heizmann CW
    Cancer; 2002 Jul; 95(2):410-9. PubMed ID: 12124842
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.
    Schüller U; Koch A; Hartmann W; Garrè ML; Goodyer CG; Cama A; Sörensen N; Wiestler OD; Pietsch T
    Int J Cancer; 2005 Oct; 117(1):82-9. PubMed ID: 15880586
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Medulloblastoma: clinical presentation and management. Experience at the hospital for sick children, toronto, 1950-1980.
    Park TS; Hoffman HJ; Hendrick EB; Humphreys RP; Becker LE
    J Neurosurg; 1983 Apr; 58(4):543-52. PubMed ID: 6827349
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biologic risk stratification of medulloblastoma: the real time is now.
    Fisher PG; Burger PC; Eberhart CG
    J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
    [No Abstract]   [Full Text] [Related]  

  • 79. Epigenetic regulation in medulloblastoma pathogenesis revealed by genetically engineered mouse models.
    Shiraishi R; Kawauchi D
    Cancer Sci; 2021 Aug; 112(8):2948-2957. PubMed ID: 34050694
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
    Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
    J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.